259 results on '"Fermand, J. P."'
Search Results
2. Current anti-myeloma therapies in renal manifestations of monoclonal light chain-associated Fanconi syndrome: a retrospective series of 49 patients
3. Nucleotide excision repair is a potential therapeutic target in multiple myeloma
4. Amyloidosis: Round Table
5. New therapeutic approaches for the myeloma patient with and without renal failure
6. Schnitzler syndrome: validation and applicability of diagnostic criteria in real‐life patients
7. Safe and prolonged survival with long-term exposure to pomalidomide in relapsed/refractory myeloma
8. High Dose Chemotherapy and Blood Stem Cell Autologous Graft in Multiple Myeloma
9. Tandem autologous non-myeloablative allogeneic transplantation in patients with multiple myeloma relapsing after a first high dose therapy
10. Consolidation with VTd significantly improves the complete remission rate and time to progression following VTd induction and single autologous stem cell transplantation in multiple myeloma
11. Impact of high-risk cytogenetics and prior therapy on outcomes in patients with advanced relapsed or refractory multiple myeloma treated with lenalidomide plus dexaméthasone
12. Physiopathology of necrobiotic xanthogranuloma with monoclonal gammopathy
13. Recovery, viability and clinical toxicity of thawed and washed haematopoietic progenitor cells: analysis of 952 autologous peripheral blood stem cell transplantations
14. Phenotypic and functional characterization of bone marrow mesenchymal stem cells derived from patients with multiple myeloma
15. Bortezomib, melphalan, and dexamethasone for light-chain amyloidosis
16. Fludarabine plus cyclophosphamide in Waldenström's macroglobulinemia: results in 49 patients
17. A clinical and pharmacological study of arsenic trioxide in advanced multiple myeloma patients
18. Schnitzler's syndrome: diagnosis, treatment, and follow-up
19. Efficiency of immunoglobulin G replacement therapy in common variable immunodeficiency: correlations with clinical phenotype and polymorphism of the neonatal Fc receptor
20. Solid Organ Tranplantation in AL Amyloidosis and Monoclonal Immunoglobulin Deposition Disease: The French Experience.: Abstract# 1520 Poster Board #-Session: P82-IV
21. Changing use of intensive care for hematological patients:: the example of multiple myeloma
22. Bortezomib in a phase 1 trial for patients with relapsed AL amyloidosis: cardiac responses and overall effects
23. Management of relapsed or refractory multiple myeloma in French hospitals and estimation of associated direct costs: a multi-centre retrospective cohort study
24. Impact of genetic abnormalities after allogeneic stem cell transplantation in multiple myeloma: report of the Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC): O161
25. HIV Protease Inhibitors Are Efficacious In Vivo in a Myeloma Mouse Model: B461
26. Intermittent Dex/Thal as Pretransplantation and Maintenance Treatment in De Novo MM: A Randomized Trial: A448
27. Dex/Thal as Induction and Maintenance Treatment in Elderly Patients with MM: A Randomized Trial: A435
28. Detection and follow-up of fibroblast growth factor receptor 3 expression on bone marrow and circulating plasma cells by flow cytometry in patients with t(4;14) multiple myeloma
29. Amyloses
30. Evaluating high dose therapy in Multiple Myeloma: Use of quality-adjusted survival analysis
31. Classification et prise en charge thérapeutique des gammapathies monoclonales de signification rénale
32. International myeloma working group recommendations for the diagnosis and management of myeloma-related renal impairment
33. Nucleotide excision repair is a potential therapeutic target in multiple myeloma
34. Lenalidomide and dexamethasone in transplant-ineligible patients with myeloma
35. Schnitzler syndrome: validation and applicability of diagnostic criteria in real-life patients
36. Current anti-myeloma therapies in renal manifestations of monoclonal light chain-associated Fanconi syndrome: a retrospective series of 49 patients
37. Étude nationale observationnelle des cutis laxa associées à une gammapathie monoclonale
38. How I treat monoclonal gammopathy of renal significance (MGRS)
39. Consensus recommendations for standard investigative workup: Report of the International Myeloma Workshop Consensus Panel 3
40. A Randomized Phase III Trial of Melphalan and Dexamethasone (MDex) versus Bortezomib, Melphalan and Dexamethasone (BMDex) for Untreated Patients with AL Amyloidosis
41. A Prospective Phase II Trial of Lenalidomide and Dexamethasone (Len-Dex) in POEMS Syndrome
42. MB4-2 breakpoint in MMSET combined with del(17p) defines a subset of t(4;14) multiple myeloma with very poor prognosis
43. Update on treatment recommendations from the fourth international workshop on Waldenström's macroglobulinemia
44. ADVANCES IN BIOLOGY AND THERAPY OF WALDENSTRÖM’S MACROGLOBULINEMIA: UPDATE ON RECOMMENDATIONS FOR ASSESSING RESPONSE FROM THE THIRD INTERNATIONAL WORKSHOP ON WALDENSTROM’S MACROGLOBULINEMIA
45. Intensive Induction Treatment in Non-Hodgkin Lymphomas with Various Grades of Malignancy
46. High dose therapy with autologous stem cell transplantation for solitary bone plasmacytoma complicated by local relapse or isolated distant recurrence
47. Échec des anti-IL1 (anakinra) dans un syndrome de Schnitzler variant IgG
48. Dermatoses neutrophiliques et gammapathies monoclonales : 26 cas et revue de la littérature
49. Transplantation d’organes solides dans l’amylose AL et la maladie de dépôts d’immunoglobulines monoclonales de type Randall : résultats d’une enquête nationale
50. Increased angiogenesis and enhanced bone formation in patients with IgM monoclonal gammopathy and urticarial skin rash: new insight into the biology of Schnitzler syndrome
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.